gr 113808 has been researched along with Nervous System Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Keczer, S; Eglen, RM; Mason, SL; Meldrum, A; Parnes, H; Reynolds, GP; Wong, EH | 1 |
| Bonhaus, DW; Eglen, RM; Hsu, S; Reynolds, GP; Wong, EH | 1 |
2 other study(ies) available for gr 113808 and Nervous System Diseases
| Article | Year |
|---|---|
5-Hydroxytryptamine (5-HT)4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases.
Topics: Aged; Aged, 80 and over; Animals; Binding, Competitive; Brain Chemistry; Female; Guinea Pigs; Humans; In Vitro Techniques; Indoles; Kinetics; Male; Middle Aged; Nerve Degeneration; Nervous System Diseases; Radioligand Assay; Receptors, Muscarinic; Receptors, Serotonin; Serotonin Antagonists; Sulfonamides | 1995 |
Characterization of [3H]GR 113808 binding to 5-HT4 receptors in brain tissues from patients with neurodegenerative disorders.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Animals; Binding, Competitive; Brain; Female; Guinea Pigs; Humans; Huntington Disease; In Vitro Techniques; Indoles; Male; Middle Aged; Nerve Degeneration; Nervous System Diseases; Parkinson Disease; Receptors, Serotonin; Serotonin Antagonists; Sulfonamides | 1996 |